European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2016 Update.

Details

Serval ID
serval:BIB_87FC66823407
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2016 Update.
Journal
Neonatology
Author(s)
Sweet D.G., Carnielli V., Greisen G., Hallman M., Ozek E., Plavka R., Saugstad O.D., Simeoni U., Speer C.P., Vento M., Visser G.H., Halliday H.L.
ISSN
1661-7819 (Electronic)
ISSN-L
1661-7800
Publication state
Published
Issued date
2017
Peer-reviewed
Oui
Volume
111
Number
2
Pages
107-125
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Advances in the management of respiratory distress syndrome (RDS) ensure that clinicians must continue to revise current practice. We report the third update of the European Guidelines for the Management of RDS by a European panel of expert neonatologists including input from an expert perinatal obstetrician based on available literature up to the beginning of 2016. Optimizing the outcome for babies with RDS includes consideration of when to use antenatal steroids, and good obstetric practice includes methods of predicting the risk of preterm delivery and also consideration of whether transfer to a perinatal centre is necessary and safe. Methods for optimal delivery room management have become more evidence based, and protocols for lung protection, including initiation of continuous positive airway pressure and titration of oxygen, should be implemented from soon after birth. Surfactant replacement therapy is a crucial part of the management of RDS, and newer protocols for surfactant administration are aimed at avoiding exposure to mechanical ventilation, and there is more evidence of differences among various surfactants in clinical use. Newer methods of maintaining babies on non-invasive respiratory support have been developed and offer potential for greater comfort and less chronic lung disease. As technology for delivering mechanical ventilation improves, the risk of causing lung injury should decrease although minimizing the time spent on mechanical ventilation using caffeine and if necessary postnatal steroids are also important considerations. Protocols for optimizing the general care of infants with RDS are also essential with good temperature control, careful fluid and nutritional management, maintenance of perfusion and judicious use of antibiotics all being important determinants of best outcome.

Pubmed
Web of science
Open Access
Yes
Create date
07/10/2016 15:53
Last modification date
20/08/2019 14:47
Usage data